BeStock  
Stocks › VRDN

Viridian Therapeutics VRDN

US equityMarket cap rank #2720
$19.00 −$0.40 (-2.06%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $19.00 0.00%
Open$19.41
Prev close$19.40
Day range$18.83 – $19.59
Volume2.65M
Market cap$2.15B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-5.6x
CheapRich

Below its usual level · 29th percentile, 5-year average -4.8x

Price / sales30.3x
CheapRich

Near the bottom of its 5-year range · 6th percentile, 5-year average 1,842.3x

#4762 of 5147 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$31.58
Price vs. fair value-39.8%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PE -5.59 -5.42 -4.77 29% (cheaper than usual) –
PS 30.26 15.63 1,842.31 6% (cheaper than usual) #4762 of 5147 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★
Fair value estimate$31.58
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on VRDN.

Leave a comment

Scroll to Top